Treace Medical Concepts Inc.
TMCI | NASDAQ
$4.48
-$0.01 (-0.22%)
At close: Sep 21, 2026, 4:00 PM ET
$4.48
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Key Executives
| Name | Position |
|---|---|
| John T. Treace | Founder, Chairman & Chief Executive Officer |
| Mark L. Hair | Chief Financial Officer |
| Brad Barr | Senior Vice President of Sales |
| Daniel E. Owens | Chief Human Resources Officer |
| Scot Elder | Chief Legal & Compliance Officer and Corporate Secretary |
| Sean F. Scanlan | Chief Innovation & Marketing Officer |
| Shana Zink | Senior Vice President of Clinical Affairs & Reimbursement |
| Taylor Erickson | Chief Information & Cybersecurity Officer |
| Terry W. Lubben | Chief Operations & Supply Chain Officer |
| Zac Potter | Senior VP & Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 24, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | 4 | Filing |
| Aug 12, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | 4 | Filing |
| Aug 12, 2026 | 4 | Filing |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | 8-K | Current Report |
| Jul 30, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 12, 2026 | 4/A | [Amend] Filing |
Treace Medical Concepts Inc.
| Country | United States |
| IPO Date | Apr 22, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 450 |
| CEO | John T. Treace |
Contact Details
100 Palmetto Park Place Ponte Vedra,
Florida 32081 United States
Stock Details
| Ticker Symbol | TMCI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001630627 |
| CUSIP Number | 89455T109 |
| ISIN Number | US89455T1097 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove TMCI